Tongmai Jiangzhuo

Tongmai Jiangzhuo is a Traditional Chinese Medicine (TCM) granule formulation developed for the early intervention of preclinical atherosclerosis (PCA). It is primarily studied by the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine. The formula is designed to "unblock the vessels and lower turbidity," targeting the metabolic and inflammatory processes involved in early-stage plaque formation. Clinical research focuses on its ability to prevent or delay the progression of atherosclerosis in high-risk populations through lifestyle intervention combined with the herbal granules.

Brand names

Tongmai Jiangzhuo Granule通脉降浊颗粒

Other names

Tongmai Jiangzhuo granules通脉降浊颗粒